DE69721497D1 - Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält - Google Patents

Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Info

Publication number
DE69721497D1
DE69721497D1 DE69721497T DE69721497T DE69721497D1 DE 69721497 D1 DE69721497 D1 DE 69721497D1 DE 69721497 T DE69721497 T DE 69721497T DE 69721497 T DE69721497 T DE 69721497T DE 69721497 D1 DE69721497 D1 DE 69721497D1
Authority
DE
Germany
Prior art keywords
nicotinic acid
blood
reducing
acid
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69721497T
Other languages
English (en)
Other versions
DE69721497T2 (de
Inventor
Ivan Furda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69721497D1 publication Critical patent/DE69721497D1/de
Application granted granted Critical
Publication of DE69721497T2 publication Critical patent/DE69721497T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69721497T 1996-02-14 1997-02-04 Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält Expired - Fee Related DE69721497T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US601388 1996-02-14
US08/601,388 US5736532A (en) 1996-02-14 1996-02-14 Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan
PCT/US1997/001635 WO1997029760A1 (en) 1996-02-14 1997-02-04 Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid

Publications (2)

Publication Number Publication Date
DE69721497D1 true DE69721497D1 (de) 2003-06-05
DE69721497T2 DE69721497T2 (de) 2004-03-18

Family

ID=24407295

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721497T Expired - Fee Related DE69721497T2 (de) 1996-02-14 1997-02-04 Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Country Status (10)

Country Link
US (1) US5736532A (de)
EP (1) EP0881903B1 (de)
JP (1) JP2000504724A (de)
AT (1) ATE238805T1 (de)
AU (1) AU1852597A (de)
DE (1) DE69721497T2 (de)
ES (1) ES2199342T3 (de)
ID (1) ID15895A (de)
WO (1) WO1997029760A1 (de)
ZA (1) ZA971134B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1100344T3 (da) 1998-07-30 2004-10-11 Vital Living Inc Chitosanholdige flydende præparater og fremgangsmåder til deres fremstilling og anvendelse
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
WO2003013471A2 (en) * 2001-08-08 2003-02-20 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
US7419655B2 (en) * 2002-09-11 2008-09-02 Kimberly-Clark Worldwide, Inc. Skin care products
GB0302741D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Use
RU2232775C1 (ru) * 2003-05-16 2004-07-20 Общество с ограниченной ответственностью "Инвест-Фарм" Способ получения ионосвязанных производных олигосахарида хитозана
US20070116713A1 (en) * 2005-11-22 2007-05-24 Gill Robert P Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
US7659313B2 (en) * 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
EP2861229B1 (de) * 2012-06-15 2020-12-23 CONARIS research institute AG Pharmazeutische zusammensetzung mit nicotinsäure und/oder nicotinamid und/oder tryptophan zur positiven beeinflussung der intestinalen mikrobiota
JP6895752B2 (ja) 2013-12-13 2021-06-30 コナリス リサーチ インスティチュート アーゲー ニコチン酸および／またはニコチンアミドを含む、腸内微生物叢を改変することにより血中脂質レベルに有益に影響を及ぼすための医薬組成物
SG11201604759UA (en) * 2013-12-13 2016-07-28 Conaris Res Inst Ag A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
ITUA20161937A1 (it) * 2016-03-23 2017-09-23 S I I T S R L Servizio Int Imballaggi Termosaldanti Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives

Also Published As

Publication number Publication date
JP2000504724A (ja) 2000-04-18
ATE238805T1 (de) 2003-05-15
ZA971134B (en) 1997-08-25
DE69721497T2 (de) 2004-03-18
WO1997029760A1 (en) 1997-08-21
US5736532A (en) 1998-04-07
EP0881903B1 (de) 2003-05-02
ES2199342T3 (es) 2004-02-16
ID15895A (id) 1997-08-14
AU1852597A (en) 1997-09-02
EP0881903A1 (de) 1998-12-09

Similar Documents

Publication Publication Date Title
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
CA2231292A1 (en) Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5198465A (en) Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
BR9810547A (pt) Absorção de minerais pelas células intestinais
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
KR920000324A (ko) 필수 지방산 처리법
DE69822832D1 (de) Therapeutische und lebensmittel-zusammensetzungen, welche essentielle fettsäuren und bioaktive disulfide enthalten
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
ES2162586A1 (es) Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
DE69620291D1 (de) Nahrungszusammensetzungen in verschiedenen Formen
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
DE69931907D1 (de) Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
CA2136614A1 (en) Nitrous oxide containing dermatological composition
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
CA2387787A1 (en) Nutritional composition for treating inflammatory bowel diseases
SE9801647D0 (sv) Therapeutic composition
GB2210789A (en) Topical application for skin care
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
EP0388237A3 (de) Diätprodukt
ATE275835T1 (de) Zinc und linolsäure enthaltendes nährungsmittel
Butterworth Jr et al. Intestinal absorption of folic acid monoglutamates and polyglutamates: A brief review of some recent developments
EP1491192A4 (de) Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
LT2001072A (lt) Maisto papildas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee